/
ANGO
$13.20-$0.20 (-1.49%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$553.7M
41M shares
52-week range
$8.36 – $13.99
86% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-13.93
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $344.3M | $359.5M | $264.2M | $291.0M | $316.2M | $338.8M | $303.9M | $292.5M |
| Cost of revenue | $117.8M | $114.6M | $113.9M | $134.2M | $150.5M | $164.5M | $149.2M | $134.8M |
| Gross profit | $143.9M | $156.0M | $150.3M | $156.8M | $165.7M | $174.2M | $154.7M | $157.7M |
| Gross margin | 41.8% | 43.4% | 56.9% | 53.9% | 52.4% | 51.4% | 50.9% | 53.9% |
| R&D | $25.5M | $29.4M | $29.7M | $36.4M | $30.7M | $29.9M | $31.5M | $26.2M |
| Operating income | −$14.2M | −$9.4M | −$167.1M | −$35.3M | −$28.5M | −$51.2M | −$192.4M | −$40.0M |
| EBITDA | $9.0M | $16.3M | −$143.4M | −$9.3M | $11.1M | $12.2M | −$6.1M | $1.7M |
| Net income | $16.3M | $61.3M | −$166.8M | −$31.5M | −$26.5M | −$52.4M | −$184.3M | −$34.0M |
| Net margin | 4.7% | 17.1% | -63.1% | -10.8% | -8.4% | -15.5% | -60.7% | -11.6% |
| EPS (diluted) | 0.44 | 1.64 | -4.37 | -0.82 | -0.68 | -1.33 | -4.59 | -0.83 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $330M | $-0.16 | $-0.25–$-0.06 | 2 |
| 2028 | $348M | $-0.03 | $-0.05–$-0.02 | 3 |
| 2029 | $368M | $0.19 | $0.06–$0.32 | 2 |
| 2030 | $392M | $0.29 | $0.29–$0.29 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$2.54
Price
$13.20
Implied downside
-81%
Peer comparison
AngioDynamics, Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
www.angiodynamics.com- Employees
- 675
- IPO / List date
- May 27, 2004
- HQ
- LATHAM, NY
Held by traders on TradeandTell
No one on the platform currently holds ANGO.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 803,283 | $9.1M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ANGO yet.
